These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 1393035)

  • 61. Denosumab for prevention of fractures in postmenopausal women with osteoporosis.
    Cummings SR; San Martin J; McClung MR; Siris ES; Eastell R; Reid IR; Delmas P; Zoog HB; Austin M; Wang A; Kutilek S; Adami S; Zanchetta J; Libanati C; Siddhanti S; Christiansen C;
    N Engl J Med; 2009 Aug; 361(8):756-65. PubMed ID: 19671655
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Importance of alfacalcidol in clinical conditions characterized by high rate of bone loss.
    Reginster JY; Lecart MP; Richy F
    J Rheumatol Suppl; 2005 Sep; 76():21-5. PubMed ID: 16142847
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Three-year denosumab treatment in postmenopausal Japanese women and men with osteoporosis: results from a 1-year open-label extension of the Denosumab Fracture Intervention Randomized Placebo Controlled Trial (DIRECT).
    Sugimoto T; Matsumoto T; Hosoi T; Miki T; Gorai I; Yoshikawa H; Tanaka Y; Tanaka S; Fukunaga M; Sone T; Nakano T; Ito M; Matsui S; Yoneda T; Takami H; Watanabe K; Osakabe T; Okubo N; Shiraki M; Nakamura T
    Osteoporos Int; 2015 Feb; 26(2):765-74. PubMed ID: 25403903
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis.
    Lindsay R; Nieves J; Formica C; Henneman E; Woelfert L; Shen V; Dempster D; Cosman F
    Lancet; 1997 Aug; 350(9077):550-5. PubMed ID: 9284777
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis.
    Storm T; Thamsborg G; Steiniche T; Genant HK; Sørensen OH
    N Engl J Med; 1990 May; 322(18):1265-71. PubMed ID: 2109197
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial.
    Black DM; Schwartz AV; Ensrud KE; Cauley JA; Levis S; Quandt SA; Satterfield S; Wallace RB; Bauer DC; Palermo L; Wehren LE; Lombardi A; Santora AC; Cummings SR;
    JAMA; 2006 Dec; 296(24):2927-38. PubMed ID: 17190893
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A double blind study of intranasal calcitonin for established postmenopausal osteoporosis.
    Kapetanos G; Symeonides PP; Dimitriou C; Karakatsanis K; Potoupnis M
    Acta Orthop Scand Suppl; 1997 Oct; 275():108-11. PubMed ID: 9385282
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Reappraisal of Katsuragi calcium study, a prospective, double-blind, placebo-controlled study of the effect of active absorbable algal calcium (AAACa) on vertebral deformity and fracture.
    Fujita T; Ohue M; Fujii Y; Miyauchi A; Takagi Y
    J Bone Miner Metab; 2004; 22(1):32-8. PubMed ID: 14691684
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effects of 5-year treatment with elcatonin and alfacalcidol on lumbar bone mineral density and the incidence of vertebral fractures in postmenopausal women with osteoporosis: a retrospective study.
    Iwamoto J; Takeda T; Ichimura S; Uzawa M
    J Orthop Sci; 2002; 7(6):637-43. PubMed ID: 12486466
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Aging bone and osteoporosis: strategies for preventing fractures in the elderly.
    Ettinger MP
    Arch Intern Med; 2003 Oct; 163(18):2237-46. PubMed ID: 14557222
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A randomized controlled trial of salmon calcitonin to prevent bone loss in corticosteroid-treated temporal arteritis and polymyalgia rheumatica.
    Healey JH; Paget SA; Williams-Russo P; Szatrowski TP; Schneider R; Spiera H; Mitnick H; Ales K; Schwartzberg P
    Calcif Tissue Int; 1996 Feb; 58(2):73-80. PubMed ID: 8998681
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Salmon calcitonin: a review of current and future therapeutic indications.
    Chesnut CH; Azria M; Silverman S; Engelhardt M; Olson M; Mindeholm L
    Osteoporos Int; 2008 Apr; 19(4):479-91. PubMed ID: 18071651
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Sustained-release sodium fluoride in the treatment of the elderly with established osteoporosis.
    Rubin CD; Pak CY; Adams-Huet B; Genant HK; Li J; Rao DS
    Arch Intern Med; 2001 Oct; 161(19):2325-33. PubMed ID: 11606148
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Rectal salmon calcitonin for the treatment of postmenopausal osteoporosis.
    Overgaard K; Hansen MA; Dirksen KL; Christiansen C
    Calcif Tissue Int; 1992 Sep; 51(3):184-8. PubMed ID: 1422962
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Calcitonin.
    Silverman SL
    Am J Med Sci; 1997 Jan; 313(1):13-6. PubMed ID: 9001161
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Patient responsiveness to calcitonin salmon nasal spray: a subanalysis of a 2-year study.
    Overgaard K; Lindsay R; Christiansen C
    Clin Ther; 1995; 17(4):680-5. PubMed ID: 8565031
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Role of peak bone mass and bone loss in postmenopausal osteoporosis: 12 year study.
    Hansen MA; Overgaard K; Riis BJ; Christiansen C
    BMJ; 1991 Oct; 303(6808):961-4. PubMed ID: 1954420
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effect of promethazine on lumbar vertebral bone mass in postmenopausal women.
    Tyan ML
    J Intern Med; 1993 Aug; 234(2):143-8. PubMed ID: 8340736
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Long-term treatment of established osteoporosis with intranasal calcitonin.
    Overgaard K; Christiansen C
    Calcif Tissue Int; 1991; 49 Suppl():S60-3. PubMed ID: 1933601
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Synthetic human calcitonin in postmenopausal osteoporosis: a placebo-controlled, double-blind study.
    Ljunghall S; Gärdsell P; Johnell O; Larsson K; Lindh E; Obrant K; Sernbo I
    Calcif Tissue Int; 1991 Jul; 49(1):17-9. PubMed ID: 1893291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.